Filter by
Selections
September 30, 2019
Arrowhead Pharmaceuticals to Participate in Upcoming October 2019 Conferences
Read MoreSeptember 20, 2019
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
Read MoreSeptember 16, 2019
Arrowhead Pharmaceuticals Presents Initial Top-Line Clinical Data and Preclinical Data on RNAi Candidates ARO-APOC3 and ARO-ANG3
Read MoreAugust 30, 2019
Arrowhead Pharmaceuticals to Participate in Upcoming September 2019 Conferences
Read MoreAugust 28, 2019